[192] observed a marked elevation in the number of tumor‐infiltrating cytotoxic CD8+ T cells in mice with knockdown of serine/arginine‐rich splicing factors following ICIs treatment, suggesting a potential boost in antitumor effects. Here, CD8A is linked to neoplasm.